General, page-887

I’m patiently waiting, while accumulation is happening for the ICL mou to become binding.

From the Dec quarterly activities report:

Progress on sales/distribution agreement for launching Alexiflam® NF with ICL

During the quarter negotiations have continued between Alexium and ICL for the latter to license and distribute Alexiflam® NF products. The focus is on ICL acting as the distributor of Alexiflam® NF products to drive commercial efforts with Alexium continuing as the manufacturer of Alexiflam® NF for the time being. Progress has been made on the agreement with the scope of the license and key terms now addressed. In parallel with the above, Alexium continues its own commercial efforts with Alexiflam® NF for key markets in which the Company will retain sales rights.